about
Characterization of Mayven, a novel actin-binding protein predominantly expressed in brainMutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathyDisruption of heart sarcoglycan complex and severe cardiomyopathy caused by beta sarcoglycan mutationsMutational analysis of the beta- and delta-sarcoglycan genes in a large number of patients with familial and sporadic dilated cardiomyopathyAlterations at the intercalated disk associated with the absence of muscle LIM proteinSarcoglycan, the heart, and skeletal muscles: new treatment, old drug?Cardiac troponin T mutations result in allele-specific phenotypes in a mouse model for hypertrophic cardiomyopathyConditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathyProtective action of tetramethylpyrazine phosphate against dilated cardiomyopathy in cTnT(R141W) transgenic miceAetiology-specific patterns in end-stage heart failure patients identified by functional annotation and classification of microarray data.The cytoskeleton of digestive epithelia in health and disease.The genetics of cardiac arrhythmias.Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathyExploring the elasticity and adhesion behavior of cardiac fibroblasts by atomic force microscopy indentation.Cardiac arrhythmias: the genetic connection.The genetic basis of cardiac function: dissection by zebrafish (Danio rerio) screens.Toward an understanding of the cause of mitral valve prolapseMolecular etiology of idiopathic cardiomyopathy.Dominant hereditary inclusion-body myopathy gene (IBM3) maps to chromosome region 17p13.1.Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice.Distinctive serum miRNA profile in mouse models of striated muscular pathologies.Molecular diagnosis of myocardial disease.Nuclear envelope proteins and neuromuscular diseases.Combined deficiency of alpha and epsilon sarcoglycan disrupts the cardiac dystrophin complex.Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray.X-Linked Dilated Cardiomyopathy: A Cardiospecific Phenotype of Dystrophinopathy.Age-matched comparison reveals early electrocardiography and echocardiography changes in dystrophin-deficient dogs.Insights into restrictive cardiomyopathy from clinical and animal studies.Specific myosin heavy chain mutations suppress troponin I defects in Drosophila musclesDilated cardiomyopathy: a tale of cytoskeletal proteins and beyond.Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.MRI to assess arrhythmia and cardiomyopathies: relationship to echocardiography.RXRalpha overexpression in cardiomyocytes causes dilated cardiomyopathy but fails to rescue myocardial hypoplasia in RXRalpha-null fetuses.Dilated cardiomyopathy caused by tissue-specific ablation of SC35 in the heart.Designing heart performance by gene transfer.Late gadolinium enhancement: precursor to cardiomyopathy in Duchenne muscular dystrophy?Genetics and genetic testing of dilated cardiomyopathy: a new perspective.Mendelian forms of structural cardiovascular disease.Complexity in simplicity: monogenic disorders and complex cardiomyopathies.Elevated rates of force development and MgATP binding in F764L and S532P myosin mutations causing dilated cardiomyopathy.
P2860
Q22010235-3EE51F9C-FC35-4536-8638-775DD5FEF8E6Q24604161-FB400015-CB99-4E5B-B2DC-CD949F019704Q24681367-7F21A416-1781-4D8A-89AE-BB71FB1DDEAEQ28177723-44AFB506-316B-48FB-AD39-B7E81B5FC3ADQ28189015-BD88359E-71F6-4A13-B0D0-B4AEA7255D9DQ28346521-F32AB9E9-72DC-4199-8BB2-6A8C30C7B48AQ28588821-2BDBFD5B-2226-44AB-B836-65EEF666EA93Q28593656-0D024056-9C12-4865-879C-15468D3E2D73Q30430580-1302BDC7-2E84-4C57-B3BC-CD9AB4C75674Q31043414-62638256-9420-44A8-A456-DAD1C8C10C5EQ33796503-9319CECB-2ED1-4491-93FB-ED28148FBB86Q33833171-517E3337-DDA1-4730-B25E-40063F72BBB9Q33854619-7583EBAD-DBF8-4E23-A18E-2BF1E5559E74Q33863581-064CAEEA-DA91-451A-8BDB-5EA879D08A73Q33926994-EE32A7F4-A510-482D-AA96-B9F2B4B1EF38Q34112808-8ABDF3A1-0399-4B27-ACDF-2D7F6559FBC5Q34145870-D532F93C-7602-433D-968D-9F5503138819Q34171604-A77E94DE-A9CB-48BC-B2BB-9DEFD2CEE297Q34389612-57DB2602-F5FB-4120-933D-25B4E672E879Q34543002-A4F546E8-7F1B-4698-8C82-E39DCC2E5631Q34589538-B18D2F26-60B7-41D0-B053-BC1999E38D83Q35016608-4806F490-BC04-496D-893E-4535652C676EQ35093315-0932EAE4-0D59-49B8-A460-E78E5CFE191CQ35532947-A22EEBD5-5EAC-44B8-B09D-05F1212F900FQ35747980-B47C2144-9FDD-42B2-902B-C09F2CC7EE92Q35818371-AABBAF92-4EF8-4B29-A121-F1B2D0BB40B1Q35819142-8C4491A8-BC6D-453E-99B5-D36EB8C66358Q36077266-168E09D2-773F-4176-8560-B460D0F38364Q36288309-81E37C90-396A-429D-AA37-6F4135457BB1Q36501691-EE935A47-5641-4C09-BDFD-7A7AE0269352Q36593277-A9DE722D-E831-46B8-83FD-501C72853E02Q36741535-10176A5B-76F5-47AC-B985-82FC362B5458Q37175349-DD166B8E-A279-4FC7-8134-42DB00287C78Q37259559-0D1B6545-459D-4E6E-A7F3-82BA77F3D3DDQ37299072-9298F0E3-2227-40EF-B247-6A7285CE9786Q37353603-45CC25C3-FCF0-42FE-A79A-E88A1E7C0F6BQ37594505-BF5C8042-7B2C-4D93-8364-491B5A0E5244Q38138883-0F3AF398-1990-4CC1-BD9B-AB3CA4EC6771Q40850987-A901BC1A-C6C5-4984-8EFF-5923536CBD3AQ41287417-85703572-32B3-446C-A7E1-2D04032CDE35
P2860
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
The role of cytoskeletal proteins in cardiomyopathies.
@en
type
label
The role of cytoskeletal proteins in cardiomyopathies.
@en
prefLabel
The role of cytoskeletal proteins in cardiomyopathies.
@en
P1476
The role of cytoskeletal proteins in cardiomyopathies.
@en
P2093
P304
P356
10.1016/S0955-0674(98)80096-3
P577
1998-02-01T00:00:00Z